Your browser doesn't support javascript.
loading
Toward Precision Medicine for Smoking Cessation: Developing a Neuroimaging-Based Classification Algorithm to Identify Smokers at Higher Risk for Relapse.
Frank, David W; Cinciripini, Paul M; Deweese, Menton M; Karam-Hage, Maher; Kypriotakis, George; Lerman, Caryn; Robinson, Jason D; Tyndale, Rachel F; Vidrine, Damon J; Versace, Francesco.
Afiliação
  • Frank DW; Department of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Cinciripini PM; Department of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Deweese MM; Department of Teaching and Learning, Peabody College at Vanderbilt University, Nashville, TN.
  • Karam-Hage M; Department of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kypriotakis G; Department of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Lerman C; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA.
  • Robinson JD; Department of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Tyndale RF; Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Departments of Psychiatry, Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
  • Vidrine DJ; Stephenson Cancer Center, Oklahoma Tobacco Research Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Versace F; Department of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
Nicotine Tob Res ; 22(8): 1277-1284, 2020 07 16.
Article em En | MEDLINE | ID: mdl-31724052
ABSTRACT

INTRODUCTION:

By improving our understanding of the neurobiological mechanisms underlying addiction, neuroimaging research is helping to identify new targets for personalized treatment interventions. When trying to quit, smokers with larger electrophysiological responses to cigarette-related, compared with pleasant, stimuli ("C > P") are more likely to relapse than smokers with the opposite brain reactivity profile ("P > C"). AIM AND

METHOD:

The goal was to (1) build a classification algorithm to identify smokers characterized by P > C or C > P neuroaffective profiles and (2) validate the algorithm's classification outcomes in an independent data set where we assessed both smokers' electrophysiological responses at baseline and smoking abstinence during a quit attempt. We built the classification algorithm applying discriminant function analysis on the event-related potentials evoked by emotional images in 180 smokers.

RESULTS:

The predictive validity of the classifier showed promise in an independent data set that included new data from 177 smokers interested in quitting; the algorithm classified 111 smokers as P > C and 66 as C > P. The overall abstinence rate was low; 15 individuals (8.5% of the sample) achieved CO-verified 12-month abstinence. Although individuals classified as P > C were nearly 2.5 times more likely to be abstinent than smokers classified as C > P (12 vs. 3, or 11% vs. 4.5%), this result was nonsignificant, preliminary, and in need of confirmation in larger trials.

CONCLUSION:

These results suggest that psychophysiological techniques have the potential to advance our knowledge of the neurobiological underpinnings of nicotine addiction and improve clinical applications. However, larger sample sizes are necessary to reliably assess the predictive ability of our algorithm. IMPLICATIONS We assessed the clinical relevance of a neuroimaging-based classification algorithm on an independent sample of smokers enrolled in a smoking cessation trial and found those with the tendency to attribute more relevance to rewards than cues were nearly 2.5 times more likely to be abstinent than smokers with the opposite brain reactivity profile (11% vs. 4.5%). Although this result was not statistically significant, it suggests our neuroimaging-based classification algorithm can potentially contribute to the development of new precision medicine interventions aimed at treating substance use disorders. Regardless, these findings are still preliminary and in need of confirmation in larger trials.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tabagismo / Algoritmos / Abandono do Hábito de Fumar / Medicina de Precisão / Neuroimagem / Fumantes Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Nicotine Tob Res Assunto da revista: SAUDE PUBLICA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tabagismo / Algoritmos / Abandono do Hábito de Fumar / Medicina de Precisão / Neuroimagem / Fumantes Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Nicotine Tob Res Assunto da revista: SAUDE PUBLICA Ano de publicação: 2020 Tipo de documento: Article